2019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty

Yale A. Fillingham,Brian Darrith,Tyler E. Calkins,Matthew P. Abdel,Arthur L. Malkani,Ran Schwarzkopf,Douglas E. Padgett,Chris Culvern,Robert A. Sershon,Stefano A. Bini,C.J. Della Valle

2019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty

2019

Yale A. Fillingham
Brian Darrith
Tyler E. Calkins
Matthew P. Abdel
Arthur L. Malkani
Ran Schwarzkopf
Douglas E. Padgett
Chris Culvern
Robert A. Sershon
Stefano A. Bini
C.J. Della Valle

Aims Tranexamic acid (TXA) is proven to reduce blood loss following total knee arthroplasty (TKA), but there are limited data on the impact of similar dosing regimens in revision TKA. The purpose o...

Keywords:

Surgery
Medicine
Tranexamic acid
Randomized controlled trial
Dosing
Arthroplasty
Revision total knee arthroplasty
total knee arthroplasty
dosing regimen
blood loss

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations